RAPILIF8/0.5

About

Rapilif 8/0.5 is a combination medication containing Silodosin (8mg) and Dutasteride (0.5mg), used for the comprehensive treatment of benign prostatic hyperplasia (BPH). Silodosin is a highly selective alpha-1A adrenergic receptor antagonist that rapidly relaxes the smooth muscles in the prostate, bladder neck, and urethra, leading to improved urine flow and immediate relief of BPH symptoms. Dutasteride is a 5-alpha reductase inhibitor that works by blocking the conversion of testosterone to dihydrotestosterone (DHT), a hormone responsible for prostate growth. This action reduces the size of the enlarged prostate over time, addressing the underlying cause of BPH progression.

This combination therapy offers both rapid symptomatic relief from the dynamic component of BPH (muscle tone) and long-term reduction in prostate volume, which addresses the static component (physical enlargement). It is particularly beneficial for men with moderate to severe BPH symptoms and an enlarged prostate, aiming to reduce the risk of acute urinary retention and the need for BPH-related surgery. Consistent adherence to the prescribed regimen is crucial for achieving optimal and sustained therapeutic outcomes.

Uses

• Treatment of moderate to severe symptoms of BPH
• Reduction of prostate size in enlarged prostates
• Decreasing the risk of acute urinary retention
• Reducing the need for BPH-related surgery

Directions For Use

Take orally, once daily, with a meal. Swallow the tablet whole; do not crush, chew, or break it.

Benefits

• Provides rapid relief of BPH symptoms
• Reduces prostate size over time
• Decreases the risk of BPH progression
• Addresses both dynamic and static components of BPH
• Improves urinary flow and reduces urgency
• Offers comprehensive long-term management of BPH

Side Effects

• Retrograde ejaculation
• Decreased libido
• Erectile dysfunction
• Ejaculatory dysfunction
• Dizziness
• Orthostatic hypotension
• Breast tenderness/enlargement
• Headache
• Diarrhea
• Nasal congestion
• Syncope
• Asthenia

Safety Measures

• Alcohol - Alcohol may increase the risk of dizziness and orthostatic hypotension when taken with this medication. It is advisable to avoid or limit alcohol consumption.
• Pregnancy - Contraindicated for women, especially pregnant women, due to the risk of fetal abnormalities (Dutasteride can cause feminization of a male fetus).
• Breastfeeding - Contraindicated for women.
• Liver - Use with caution; not recommended in severe hepatic impairment for Silodosin. Dutasteride is extensively metabolized by the liver, so caution is advised in liver conditions.
• Kidney - Dose adjustment required for Silodosin in moderate renal impairment; contraindicated in severe renal impairment. Dutasteride generally does not require adjustment.
• Lung - Generally safe; caution is advised if severe respiratory conditions predispose to syncope (due to Silodosin component).

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.